首页> 美国卫生研究院文献>American Journal of Physiology - Renal Physiology >Functional immunoassay technology (FIT) a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR)
【2h】

Functional immunoassay technology (FIT) a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR)

机译:功能免疫测定技术(FIT)一种测量生理功能的新方法:FIT在测量肾小球滤过率(GFR)中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This is the first description of functional immunoassay technology (FIT), which as a diagnostic tool has broad application across the whole spectrum of physiological measurements. In this paper, FIT is used to measure the renal clearance of an ultra low-dose administration of a clinically available contrast reagent for the purpose of obtaining an accurate glomerular filtration rate (GFR) measurement. Biomarker-based GFR estimates offer convenience, but are not accurate and are often misleading. FIT overcomes previous analytic barriers associated with obtaining an accurate GFR measurement. We present the performance characteristics of this diagnostic test and demonstrate the method by directly comparing GFR values obtained by FIT to those obtained by an FDA approved nuclear test in 20 adults. Two subjects were healthy volunteers and the remaining 18 subjects had diagnosed chronic kidney disease, with 12 being kidney transplant recipients. Measured GFR values were calculated by the classic UV/P method and by the blood clearance method. GFR obtained by FIT and the nuclear test correlated closely over a wide range of GFR values (10.9–102.1 ml·min−1·1.73 m−2). The study demonstrates that FIT-GFR provides an accurate and reproducible measurement. This nonradioactive, immunoassay-based approach offers many advantages, chiefly that most laboratories already have the equipment and trained personnel necessary to run an ELISA, and therefore this important diagnostic measurement can more readily be obtained. The FIT-GFR test can be used throughout the pharmaceutical development pipeline: preclinical and clinical trials.
机译:这是功能性免疫测定技术(FIT)的首次描述,该技术作为诊断工具已在整个生理测量范围中得到广泛应用。在本文中,为了获得准确的肾小球滤过率(GFR)测量值,FIT用于测量临床使用的造影剂的超低剂量给药的肾脏清除率。基于生物标志物的GFR估算值提供了便利,但不准确,并且经常会产生误导。 FIT克服了以前与获得精确GFR测量相关的分析障碍。我们介绍了该诊断测试的性能特征,并通过直接比较FIT获得的GFR值与FDA批准的20名成年人进行的核试验获得的GFR值来演示该方法。 2名受试者为健康志愿者,其余18名受试者已诊断出慢性肾脏疾病,其中12名为肾脏移植受者。通过经典的UV / P方法和血液清除方法计算测得的GFR值。 FIT和核试验得到的GFR在很大的GFR值之间密切相关(10.9–102.1 ml·min -1 ·1.73 m −2 )。该研究表明FIT-GFR提供了准确且可重复的测量结果。这种基于非放射性,免疫测定的方法具有许多优势,主要是大多数实验室已经拥有运行ELISA所需的设备和训练有素的人员,因此可以更轻松地获得这种重要的诊断测量结果。 FIT-GFR测试可在整个药物开发流程中使用:临床前和临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号